Privacy

PrivacyHIPAA Compliance
PRi is committed to protecting patient candidate information in a regulated, private and secure environment. We govern this with in-house Standard Operating Procedures (SOP), HIPAA regulatory standards, and our published Privacy Policy Notice. All SOPs are available for client audit and review. PRi is diligent in our compliance and maintenance with internal SOPs and has institutionalized regular employee-training programs, which are mandatory for all employees.

Our Commitment to Privacy
Through PRi course of business, persons responding to Clinical Trial Advertising, Clinical Investigator, Physician and Healthcare Provider information collected through Investigator and Patient Recruitment activities are highly protected, removed or coded depending upon the intended clinical trial application at hand. PRi employs measures used in the clinical trial industry to recruit and inform study candidates and participants about the respective clinical trial research. Clinical Investigators and their requisite Institutions selected to conduct clinical trials may also provide additional information in accordance with industry standards.

Individual’s Decision
Any individual that submits personally identifiable information to PRi is provided advance notice of the use of such information. Those individuals will be given the opportunity to choose (opt-out) with regard to the protection of information to be: (a) disclosed to a third party or (b) used for a purpose that is incompatible with the purpose or purposes for which it was originally collected or subsequently authorized by the individual.

For sensitive information (information including health conditions, racial or ethnic origin, religious or philosophical beliefs, trade union membership or information specifying the gender or sex preference of the individual), an individual will be given the explicit (opt-in) choice for that information to be disclosed to a third party or used for a purpose other than that for which it was originally collected or subsequently authorized by the individual through the exercise of the opt-in choice.

Commitment to Data Security
PRi upholds a high level of security in connection to protecting its data. Computer systems, equipment, networks, programs, data, and documentation are secured to the extent reasonably practicable using existing technology, as is customary, if not otherwise regulated, in the pharmaceutical research industry. Access to data and equipment is restricted to appropriate staff on a need to know basis. PRi also makes best efforts to conform its data security policies to the respective national and international data protection and confidentiality regulations governing the performance of clinical research.

Data Integrity
Personal information collected by PRi is used solely for the purposes expressed at the time of collection unless you authorize otherwise. PRi endeavors to collect and maintain only information that is accurate, complete, and current.

Access
Generally, an individual that provides identifiable information to PRi has the right to reasonable access to that information. PRi collects information for the purposes of clinical research patient recruiting or for medical opinion collection. Clinical research information is collected in a manner that is consistent with a sponsoring organizations (i.e. pharmaceutical company) clinical trial protocol, and is submitted for review by an appropriate U.S. FDA sanctioned ethics review committee called an Institutional Review Board or IRB.

If an individual study participant desires access, it can be requested through the investigator or physician from whom the participant received treatment in accordance with customary practices and regulations in the pharmaceutical industry.